Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 0.63 |
| ▸ | PTGDR | Q13258 | 5/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | PTGIR | P43119 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155945 | 0.92 | PTGDR2 (0.66) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL152376 | 0.90 | PTGDR2 (0.64) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL136353 | 0.83 | PTGDR2 (0.67) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL137147 | 0.81 | PTGDR2 (0.65) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL137965 | 0.81 | PTGDR2 (0.65) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL137382 | 0.80 | PTGDR2 (0.66) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL134776 | 0.79 | PTGDR2 (0.62) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL137393 | 0.79 | PTGDR2 (0.88) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL137898 | 0.78 | PTGDR2 (0.60) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 | |
| SCHEMBL10324111 | 0.78 | PTGDR2 (0.87) | PTGDR2PTGDRCYP3A4TBXA2RCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2257524-B1 | N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS | BRICKELL BIOTECH INC (US) | 2016-01-06 | — | — | EP | disclosed |